These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9472637)

  • 21. Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells.
    Carapeti M; Aguiar RC; Sill H; Goldman JM; Cross NC
    Br J Cancer; 1998 Sep; 78(5):601-5. PubMed ID: 9744498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
    van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. fhit Alterations in endometrial carcinoma and hyperplasia.
    Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y
    Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant FHIT transcripts in Merkel cell carcinoma.
    Sozzi G; Alder H; Tornielli S; Corletto V; Baffa R; Veronese ML; Negrini M; Pilotti S; Pierotti MA; Huebner K; Croce CM
    Cancer Res; 1996 Jun; 56(11):2472-4. PubMed ID: 8653678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of FHIT gene alterations in ovarian cancer.
    Buttitta F; Marchetti A; Radi O; Bertacca G; Pellegrini S; Gadducci A; Genazzani AR; Bevilacqua G
    Br J Cancer; 1998 Apr; 77(7):1048-51. PubMed ID: 9569038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
    Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.
    Schlott T; Ahrens K; Ruschenburg I; Reimer S; Hartmann H; Droese M
    Br J Cancer; 1999 Apr; 80(1-2):73-8. PubMed ID: 10389981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue.
    Tokuchi Y; Kobayashi Y; Hayashi S; Hayashi M; Tanimoto K; Hashimoto T; Nishida K; Ishikawa Y; Nakagawa K; Satoh Y; Yamamoto M; Tsuchiya E
    Genes Chromosomes Cancer; 1999 Feb; 24(2):105-11. PubMed ID: 9885976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal transcripts of FHIT gene in thyroid cancer.
    Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH
    Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression and deletion of FHIT gene in leukemias.
    Wang L; Dong LJ; Tian F; Liu GX; Li CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma.
    Hinohara S; Satake N; Sekine K; Kaneko Y
    Jpn J Cancer Res; 1998 Sep; 89(9):887-94. PubMed ID: 9818023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers].
    Duan XM; Zhang GY; Wu ES
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased or altered expression of the FHIT gene in human leukemias.
    Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
    Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired FHIT expression characterizes serous ovarian carcinoma.
    Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
    Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
    Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.